Unity Biotechnology, Inc. Deferred Tax Assets, Goodwill and Intangible Assets
Unity Biotechnology, Inc. had Deferred Tax Assets, Goodwill and Intangible Assets of $1.24 million as of 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2025-03-07
- 2024-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $1.24M.
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $1.34M.
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $5.33M.
- 2021-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $3.58M.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2024-12-31 | $1.24M 10-K · filed 2025-03-07 |
| 2023-12-31 | $1.34M 10-K · filed 2025-03-07 |
| 2022-12-31 | $5.33M 10-K · filed 2024-04-15 |
| 2021-12-31 | $3.58M 10-K · filed 2023-03-15 |
| 2020-12-31 | $1.18M 10-K · filed 2022-03-15 |
| 2019-12-31 | $241.00K 10-K · filed 2021-03-23 |